C-Rad AB (publ) Total Liabilities
C-Rad AB (publ) total liabilities. Based on the latest financial reports, C-Rad AB (publ) (CRAD-B) has total liabilities worth Skr153.60 Million SEK (≈ $16.53 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CRAD-B asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of C-Rad AB (publ) (2008–2025)
Total liabilities of C-Rad AB (publ) from 2008 to 2025. This chart illustrates how C-Rad AB (publ)'s total liabilities have evolved over time, based on quarterly financial data.
C-Rad AB (publ) Competitors by Total Liabilities
The table below lists competitors of C-Rad AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Renergen Ltd
AU:RLT
|
Australia | AU$1.70 Billion |
|
Nan Liu Enterprise Co Ltd
TW:6504
|
Taiwan | NT$6.18 Billion |
|
Hipages Group Holdings Ltd
AU:HPG
|
Australia | AU$24.56 Million |
|
Micropolis Holding Company
NYSE:MCRP
|
USA | $40.58 Million |
|
Southern Concrete Pile PCL
BK:SCP
|
Thailand | ฿617.65 Million |
|
IX Acquisition Corp
NASDAQ:IXAQ
|
USA | $13.70 Million |
|
Choppies Enterprises Ltd
JSE:CHP
|
South Africa | ZAC2.83 Billion |
|
Lumi Gruppen AS
OL:LUMI
|
Norway | Nkr551.59 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down C-Rad AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see C-Rad AB (publ) balance sheet assets.
Liquidity & Leverage Metrics
C-Rad AB (publ) Total Liabilities Ratios Explained
C-Rad AB (publ) total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how C-Rad AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for C-Rad AB (publ) (2008–2025)
The table below shows the annual total liabilities of C-Rad AB (publ) from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr153.60 Million ≈ $16.53 Million |
-6.55% |
| 2024-12-31 | Skr164.37 Million ≈ $17.69 Million |
+34.29% |
| 2023-12-31 | Skr122.40 Million ≈ $13.17 Million |
+26.67% |
| 2022-12-31 | Skr96.63 Million ≈ $10.40 Million |
+27.79% |
| 2021-12-31 | Skr75.62 Million ≈ $8.14 Million |
+6.90% |
| 2020-12-31 | Skr70.73 Million ≈ $7.61 Million |
-5.00% |
| 2019-12-31 | Skr74.46 Million ≈ $8.01 Million |
+40.56% |
| 2018-12-31 | Skr52.97 Million ≈ $5.70 Million |
+13.55% |
| 2017-12-31 | Skr46.65 Million ≈ $5.02 Million |
+48.09% |
| 2016-12-31 | Skr31.50 Million ≈ $3.39 Million |
-6.19% |
| 2015-12-31 | Skr33.58 Million ≈ $3.61 Million |
+2.92% |
| 2014-12-31 | Skr32.63 Million ≈ $3.51 Million |
+37.41% |
| 2013-12-31 | Skr23.74 Million ≈ $2.56 Million |
+8.61% |
| 2012-12-31 | Skr21.86 Million ≈ $2.35 Million |
+20.19% |
| 2011-12-31 | Skr18.19 Million ≈ $1.96 Million |
-7.69% |
| 2010-12-31 | Skr19.70 Million ≈ $2.12 Million |
+31.18% |
| 2009-12-31 | Skr15.02 Million ≈ $1.62 Million |
+12.65% |
| 2008-12-31 | Skr13.33 Million ≈ $1.43 Million |
-- |
About C-Rad AB (publ)
C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solut… Read more